CME Group
CME
Market cap $98.8B

274.60 USD

+0.48

0.18%

At close Jul 29, 4:00 PM EDT

After hours

275.15

+0.55

0.20%

1 day

0.18%

5 days

0.14%

1 month

-0.37%

3 months

0.82%

6 months

18.11%

Year to date

18.00%

1 year

38.05%

5 years

66.55%

10 years

183.06%

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

Financials Financial Data & Stock Exchanges

0

Funds holding %

of 7,323 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

125% more first-time investments, than exits

New positions opened: 207 | Existing positions closed: 92

36% more call options, than puts

Call options by funds: $579M | Put options by funds: $427M

17% more funds holding in top 10

Funds holding in top 10: 53 [Q4 2024] → 62 (+9) [Q1 2025]

16% more capital invested

Capital invested by funds: $74.4B [Q4 2024] → $86.6B (+$12.2B) [Q1 2025]

6% more funds holding

Funds holding: 1,473 [Q4 2024] → 1,562 (+89) [Q1 2025]

6% more repeat investments, than reductions

Existing positions increased: 586 | Existing positions reduced: 552

0.19% more ownership

Funds ownership: 88.09% [Q4 2024] → 88.28% (+0.19%) [Q1 2025]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$275

0%

upside

Avg. target

$295

8%

upside

High target

$305

11%

upside

5 analyst ratings

2 positive

40%

3 neutral

60%

0 negative

0%

UBS Alex Kramm	11%upside $305	Neutral Downgraded	24 Jul 2025
Oppenheimer Owen Lau	10%upside $303	Outperform Maintained	24 Jul 2025
Barclays Benjamin Budish	9%upside $298	Equal-Weight Maintained	24 Jul 2025
Piper Sandler Patrick Moley	8%upside $296	Overweight Maintained	15 Jul 2025
Citigroup Christopher Allen	0%upside $275	Neutral Maintained	3 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 24 articles about CME published over the past 30 days

The Motley Fool

CME Group Revenue Jumps 10% in Q2

CME Group (CME -0.41%), the major derivatives exchange operator known for its futures and options markets, reported financial results for the second quarter of 2025 on July 23, 2025. The company delivered record revenue of $1.7 billion, surpassing the consensus GAAP revenue estimate of $1.69 billion.

CME Group Revenue Jumps 10% in Q2

CME Group Wins Lawsuit by Former Floor Traders

A jury rejects claims that the exchange operator broke its deal with traders when it shifted to electronic markets.

CME Group Wins Lawsuit by Former Floor Traders

CNBC Television

Josh Brown's 'Best Stocks in the Market': CBOE Global Markets

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to spotlight another name on his "Best Stocks in the Market."

Josh Brown's 'Best Stocks in the Market': CBOE Global Markets

CME Group Inc. (CME) Q2 2025 Earnings Conference Call Transcript

CME Group Inc. (NASDAQ:CME ) Q2 2025 Earnings Call July 23, 2025 8:30 AM ET Company Participants Adam Minick - Investor Contact Terrence Duffy - Chairman & CEO Lynne Fitzpatrick - President & CFO Julie Winkler - Senior MD & Chief Commercial Officer Tim McCourt - Senior MD & Global Head of Equities, FX and Alternative Products Derek Sammann - Senior MD & Global Head of Commodities Markets Suzanne Sprague - Senior MD, Group COO & Global Head of Clearing Michael Dennis - Senior Managing Director & Global Head of Fixed Income Conference Call Participants Kwun Sum Lau - Oppenheimer & Co. Inc., Research Division Brian Bedell - Deutsche Bank AG, Research Division Christopher Allen - Citigroup Inc., Research Division Elias Abboud - BofA Securities, Research Division Daniel Fannon - Jefferies LLC, Research Division Alex Kramm - UBS Investment Bank, Research Division Kenneth Worthington - JPMorgan Chase & Co, Research Division Patrick Moley - Piper Sandler & Co., Research Division Michael Cyprys - Morgan Stanley, Research Division Kyle Voigt - Keefe, Bruyette, & Woods, Inc., Research Division Benjamin Budish - Barclays Bank PLC, Research Division Alexander Blostein - Goldman Sachs Group, Inc., Research Division Simon Alistair Clinch - Redburn (Europe) Limited, Research Division William Katz - TD Cowen, Research Division William Qi - RBC Capital Markets, Research Division Operator Welcome to the CME Group Second Quarter 2025 Earnings Call. [Operator Instructions] I would now like to turn the call over to Adam Minick.

CME Group Inc. (CME) Q2 2025 Earnings Conference Call Transcript

The Motley Fool

CME Group Posts Record Q2 Revenue Up 10%

CME Group (CME 0.54%), the large U.S. derivatives and financial exchange operator, reported record-setting results for the quarter ended June 30, 2025. In its July 23, 2025, earnings release, the company announced revenue of $1.7 billion and adjusted earnings per share of $2.96.

CME Group Posts Record Q2 Revenue Up 10%

Zacks Investment Research

CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume

CME posts Q2 beats on earnings and revenue as record trading volume and rising fees lift results amid market volatility.

CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume

Zacks Investment Research

Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings

The headline numbers for CME (CME) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings

Zacks Investment Research

CME Group (CME) Surpasses Q2 Earnings and Revenue Estimates

CME Group (CME) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.91 per share. This compares to earnings of $2.56 per share a year ago.

CME Group (CME) Surpasses Q2 Earnings and Revenue Estimates

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

Record revenue of $1.7 billion, up 10% from Q2 2024 Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024 CHICAGO , July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025.

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

Zacks Investment Research

Is a Beat in the Cards for CME Group This Earnings Season?

CME's second-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.

Is a Beat in the Cards for CME Group This Earnings Season?

See News Rankings

Charts implemented using Lightweight Charts™